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The present study aims at integrating drug-releasing materials with signal-processing 
biocomputing systems. Enzymes alanine transaminase (ALT) and aspartate transaminase 
(AST)—biomarkers for liver injury—were logically processed by a biocatalytic cascade 
realizing Boolean AND gate. Citrate produced in the system was used to trigger a drug-
mimicking release from alginate microspheres. In order to differentiate low vs. high 
concentration signals, the microspheres were coated with a protective shell composed of 
layer-by-layer adsorbed poly(L-lysine) and alginate. The alginate core of the 
microspheres was prepared from Fe3+-cross-linked alginate loaded with rhodamine 6G 
dye mimicking a drug. Dye release from the core occurred only when both biomarkers, 
ALT and AST, appeared at their high pathophysiological concentrations jointly indicative 
of liver injury. The signal-triggered response was studied at the level of a single 
microsphere, yielding information on the dye release kinetics. 
________________________________________________________________________ 
 
An integrated system logically 
processing biomarkers and releasing a 
drug-mimicking material was developed 
to demonstrate a new “Sense-Act-Treat” 
concept. 
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1. INTRODUCTION 
 
The design of new controlled-release chemical systems has received considerable 
attention due to their advantages in various areas including fragrance release,1 self-
healing materials2,3 and particularly for delivery of bioactive substances (drugs, vitamins, 
nutrients, contrasts for imaging, genes, etc.) in various biomedical applications.4-10 The 
therapeutic potential of these systems is especially strong because they can provide 
solutions for the easy control of drug transport, tackling the problem of localized delivery 
to a specific site.11-13 Various functional materials based on polymer thin-films,14-16 
membranes,17 nanoporous18 and mesoporous19,20 structures, capsules21-23 and 
liposomes24,25 are capable of entrapping various molecular species and nano-objects and 
then releasing them in response to different physical or chemical signals. A variety of 
polymers9-12 have been used over the past few decades for encapsulating drugs and their 
subsequent delivery. Persistent challenges associated with loading of the desired 
molecules with high efficiency, preserving activity and stabilizing the encapsulated 
species, and preventing their leaching, require the development of new polymer materials 
and techniques to design systems with complex architectures. Among the different 
techniques, the polyelectrolyte layer-by-layer (LbL) self-assembly has emerged as an 
easily utilized and versatile tool.26-29 Based on alternating adsorption of polycations and 
polyanions, this technique allows films to be produced with tunable properties; an almost 
infinite variety of architectures can thus be obtained.30-32 Stimuli-responsive LbL-
polymeric assemblies have been used in particular for the controlled release of drugs.33-36  
 
Alginate, a natural polymer,37 due to its appealing adhesive and mechanical properties 
together with availability, compatibility with hydrophobic and hydrophilic molecules, 
and lack of toxicity, has attracted increasing interest. Alginate hydrogels, ionically cross-
linked in the presence of multivalent cations, have been extensively investigated owing to 
their biocompatibility.37 Notably, alginate hydrogels have been utilized as microcapsules 
that can release entrapped components either spontaneously or in response to changes in 
environmental conditions, through controlled degradation of the assembly.38-43 However, 
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it is known that ionically cross-linked alginate hydrogel is not structurally stable, because 
of ion exchange, especially under physiological conditions, limiting its medical 
application.37 A number of studies have attempted to address this problem by varying the 
molecular weight44,45 or/and cross-linking ions45 of alginate. Since alginate contains 
carboxylic groups on polyguluronate units, alginate microspheres exhibit negative surface 
charge,46 allowing them to be used as negatively charged templates for polyelectrolyte 
LbL assembly. Different polyelectrolytes have been used to coat alginate,47-53 where the 
most common system involves alginate/poly-L-lysine/alginate (APA) assembly,54-57 
derived from the original protocol of Lim and Sun.58 This system consists of an alginate 
core ionically cross-linked with multivalent cations (often Ca2+).59 These microspheres 
are coated with poly(L-lysine) to strengthen the outer surface and control permeability,60 
followed by coating with a capping layer of adsorbed alginate to shield the cationic 
poly(L-lysine) from the environment and, thus, make the microcapsules biocompatible.61 
 
Due to the intrinsic ability of polymers to alter their physical and chemical properties 
in response to external stimuli, utilization of polymers in drug delivery fosters 
development of systems triggered by different signals, particularly by pH changes,62-66 
temperature variation66 and presence of specific biomolecules (e.g., glucose).66,67 
Biochemical reactions resulting in change of pH, temperature or increase/decrease in 
concentration of certain molecules can therefore initiate drug release. It is known that 
biochemically induced changes in physiological conditions often relate to the occurrence 
of a certain biological dysfunction or disease. Therefore design of systems triggered 
directly by changes in physiological conditions has been of high importance for medical 
diagnostics and physiologically regulated drug release. Thus far, triggered-release 
reactions have been accomplished via the interaction of signal-responsive materials with 
a single external signal, e.g., the presence of one specific kind of biomolecule.66,67 
Development of signal-responsive materials recognizing the concentration changes of 
several biomolecules simultaneously and responding  only to specific combinations of the 
(bio)chemical signals would enable new biomedical applications.68  
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Information processing by biomolecules (shortly, “biocomputing”),69,70 originally 
studied as a sub-area of unconventional computing,71,72 has recently been researched as a 
new important tool for biosensing73,74 and bioactuating.75 Biomedical application of 
biocomputing systems allows logic analysis of complex patterns of simultaneously 
varying biomarkers jointly characteristic of different pathophysiological conditions.76-78 
Particularly, enzyme-based biocomputing systems79 in the form of single logic gates80-82 
or complex logic networks83 were utilized for the analysis of biomarkers signaling 
different injury conditions. Integration of enzyme logic gates with switchable electrodes 
allowed activation of bioelectrochemical systems by appropriate combinations of 
biomarkers appearing at elevated pathophysiological concentrations.84 It should be noted 
that the designed switchable bioelectrodes were controlled by complex patterns of 
biochemical signals85 rather than a single physical or chemical signal. 
 
The present paper represents the next step in the development of biochemical systems 
controlled by logically processed biochemical signals with the result that a drug-
mimicking material is released only when both biomarker-signals appeared at their high 
pathophysiological concentrations jointly indicative of liver injury. Thus, this work 
extends the research on multi-input biosensors with the built-in biomolecular logic to 
include an “actuator” which responds to the output signal of the binary logic processing. 
The signal-triggered response was studied at the level of a single microsphere, yielding 
information on the release kinetics of the drug-mimicking dye. 
 
 
2. EXPERIMENTAL SECTION 
 
Chemicals and reagents. Alanine transaminase from porcine heart (ALT, E.C. 2.6.1.2), 
aspartate transaminase, type 1 (AST, E.C. 2.6.1.1), citrate synthase from porcine heart 
(E.C. 2.3.3.1), glutamic acid, pyruvic acid, aspartate sodium salt, acetyl coenzyme A 
sodium salt (acetyl CoA), 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), alginic acid 
sodium salt from brown algae (medium viscosity, ≥ 2,000 cP), poly-L-lysine 
hydrobromide (mol. wt. 30,000-70,000), fluorescein isothiocyanate (FITC)-labeled poly-
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L-lysine (mol. wt. 30,000-70,000), rhodamine 6G, 3-(N-morpholino)propanesulfonic acid 
(MOPS buffer) and other standard organic / inorganic chemicals were purchased from 
Sigma-Aldrich, J. T. Baker and Fisher Scientific and used as supplied without any 
pretreatment or further purification. All solutions were prepared using ultrapure water 
(18.2 MΩ·cm; Barnstead NANOpure Diamond). The experiments were performed at 
ambient temperature, 25°C ± 2°C. 
 
Instrumentation and measurements. Fluorescent measurements were performed using 
fluorescent spectrophotometer (Varian, Cary Eclipse). Confocal micrographs were taken 
with Scanning Laser Confocal Fluorescence Microscope, Nikon Eclipse C1 (488 nm 
argon-ion laser was used) with 10-CFI objective. Images from the confocal microscope 
were handled using EZ-C1 Software Version 3.10 (Nikon Corporation). 
 
Fabrication of rhodamine 6G-loaded alginate hydrogel microspheres. Sodium alginate 
was dissolved in water at 37ºC overnight to yield 1% (w/v) solution. Then 1.5 mL 
alginate solution was vigorously mixed with 0.1 mL, 0.9 mg/mL, rhodamine 6G solution 
in 20 mM MOPS buffer, pH 7.4. Note that the rhodamine 6G dye was used to mimic a 
drug molecule. The viscous alginate-rhodamine solution was pressed through a 31-gauge 
needle forming droplets. Compressed air (ca. 125 PSI, 30 L/min) was used to shear the 
droplets coming out of the tip of the needle. Alginate hydrogel formation in the form of 
microspheres occurred upon contact of the droplets with 1% (w/v) FeCl3, dissolved in 
deionized water, for 15 min. After formation the microspheres were filtered from the 
solution using a gravity funnel apparatus and transferred to a Petri dish where they were 
washed with water twice and stored in deionized water at room temperature.  
 
LbL assembly of poly-L-lysine /alginate on the alginate microspheres. Poly-L-lysine and 
alginate were dissolved in concentrations of 0.05% (w/v) and 0.5% (w/v) in 20 mM 
MOPS buffer, pH 7.4, and deionized water respectively. These solutions were used to 
deposit first a layer of poly-L-lysine and then a second layer of alginate on the Fe3+-
cross-linked alginate microspheres loaded with rhodamine 6G. Each deposition step 
proceeded for 5 min and the coated microspheres were washed with water after each 
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polymer adsorption step. The final alginate/poly-L-lysine/alginate (APA) microspheres 
were composed of a central core consisting of the Fe3+-cross-linked alginate hydrogel 
loaded with rhodamine 6G dye coated with electrostatically bound polymer shells of 
poly-L-lysine and sodium alginate. 
 
The characterization of the alginate hydrogel microspheres. The size distribution of the 
rhodamine 6G-loaded microspheres in aqueous solutions before drug-mimicking release 
was visualized by confocal microscopy. The rhodamine 6G dye was excited with a 488 
nm argon laser and became visible using scanning laser confocal fluorescence 
microscopy under 10-objective lens. The produced microspheres ranged in size from 
500 to 800 μm, however, only microspheres with the size of ca. 500 μm were selected for 
the experiments. FITC-labeled poly-L-lysine was used to visualize the poly-L-lysine 
layer applied to the microspheres. The microspheres treated with FITC-labeled poly-L-
lysine were produced in the same way as described above, however the addition of 
rhodamine 6G dye to the initial sodium alginate solution was skipped because the FITC-
label has excitation and emission spectrum peaks (495 nm and 521 nm respectively) 
similar to those of rhodamine 6G. 
 
The composition of the biocatalytical cascade for the liver injury analysis. Glutamic acid 
(10 mM), pyruvic acid (5 mM), aspartate sodium salt (50 mM), acetyl CoA (5 mM), and 
citrate synthase (1 U/mL) were dissolved in phosphate buffer saline (PBS) (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4), pH = 7.4, to form the 
“machinery” of the system. Logical ‘0’ and ‘1’ levels of ALT (0.02 and 2 U/mL), and 
AST (0.02 and 2 U/mL) which correspond to the normal and pathophysiological 
biomarker concentrations,86 respectively, were used as inputs A and B activating the 
biochemical “machinery” system. This system works as an AND gate, signaling presence 
of the liver injury when both inputs appear at their logic 1 concentrations. Production of 
citrate was indirectly measured for each combination of the inputs using interaction 
between DTNB87,88 reagent and a thiol group of CoASH which is produced by the 
biocatalytic cascade in 1:1 stoichiometry to citrate, see Scheme 1 (all the Schemes and 
Figures are located at the end of this preprint, starting on page 25). For this analysis, after 
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1 hour of the biocatalytic reaction, 50 μL aliquot of the reaction mixture was reacted with 
10 μL of DTNB (0.1 mM) and the absorbance at 412 nm was used to calculate87,88 the 
concentration of the produced CoASH. The concentration of citrate was assumed to be 
the same. In order to determine the total amount of the loaded rhodamine 6G dye, 
individual microspheres were fully dissolved in 10 mM citrate solution for 30 min and 
the amount of the released rhodamine 6G was found by fluorescence measurements. 
 
In vitro release study. In order to measure the rhodamine 6G dye release to the solution, 
triggered by the biocatalytic cascade for the analysis of liver injury, single microspheres 
were isolated and placed in different cuvettes containing the “machinery” system. By 
application of different ALT/AST input combinations to different cuvettes the 
fluorescence of the released rhodamine 6G was measured every 5 min for the system with 
mixing and every 10 min for undisturbed system. Mixing was done with pipette 3 times 
up and down each time before the measurement. For the experiments without mixing, a 
light beam passed through a horizontal slit 1 mm wide to excite fluorescence at a thin 
slice of solution inside the cuvette at 6 mm above the bottom, where a single rhodamine 
6G-loaded microsphere was placed. 
 
In order to directly visualize the kinetics of the microsphere dissolution, a single 
microsphere was placed on a microscope glass slide and observed by using a confocal 
microscope. The microspheres were dissolved in different solutions mimicking 
production of citrate in situ from the biocatalytic cascade. Citrate, 0.34 mM solution, was 
used to mimic the result of the application of ALT/AST inputs in 1,0 combination, while 
1 mM solution was selected to mimic the 1,1 input combination. In a control experiment 
ascorbic acid, 1 mM, was used to visualize the kinetics of the microsphere dissolution 
and compare it with the equivalent concentration of citrate. The kinetics of the dissolution 
was represented as change in pixels brightness of the background which was found by 
demarcating a small square of pixels on the image and monitoring their brightness over 
time, as the microspheres dissolved. The analyzed square was drawn in the top-left corner 
of each image. 
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Movies showing time-dependent dissolution of the APA microspheres in the presence 
of 0.34 and 1 mM citrate are available in the Electronic Supplementary Information. The 
imaging was performed by using Scanning Laser Confocal Fluorescence Microscope, 
Nikon Eclipse C1 (488 nm argon-ion laser was used with 10-objective) where pictures 
were taken every 2 min. Movies were composed in Windows Movie Maker program 
from the pictures obtained from the microscope.  The movie for 0.34 mM of 
citrate, composed of 30 frames, corresponds to the monitoring of the microsphere 
dissolution during the time of 60 min. The movie for 1 mM of citrate, composed of 13 
frames, corresponds to the observation of the microsphere dissolution during 26 min. 
 
 
3. RESULTS AND DISCUSSION 
 
Scheme 1 shows the general composition and operation of the system with the drug-
mimicking release from the alginate microspheres triggered by a biocatalytic cascade 
activated by biomarkers signaling liver (hepatic) injury. This system is based on the 
recently developed concept of two non-specific biomarkers operating together, and it 
offers a high fidelity indication of liver injury when both biomarkers appear at their 
elevated pathophysiological concentrations.73,74,80-82 The biomarker selection in each case 
is based on their biomedical relevance to the specific pathophysiological condition and on 
their ability to operate jointly in a biocatalytic cascade producing the final desired 
product. In order to provide a binary “YES/NO” conclusion on specific 
pathophysiological conditions, for an analytical application the end product generated by 
the biocatalytic cascade should be easily analyzed by optical80-82 or electrochemical81 
means. The present work is focused on the actuation involved in the model drug release, 
and therefore the final product generated by the biocatalytic cascade should dissolve the 
alginate microcapsules, releasing the loaded dye.  
 
Two enzymes, alanine transaminase (ALT) and aspartate transaminase (AST), were 
selected as biomarkers signaling liver injury. While they appear in human blood at 
concentration of 0.02 U/mL under normal physiological conditions, their elevated 
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concentrations of 2 U/mL correspond to pathophysiological conditions characteristic of 
the liver injury.86 Therefore, we defined 0.02 and 2 U/mL concentrations as logic inputs 0 
and 1, respectively, while the “gate machinery” included the rest of the system, see 
Scheme 1, identical for each combination of the logic inputs. Since all experiments were 
performed in vitro, the “machinery” solution was activated with the model solutions 
containing the ALT and AST biomarkers at the concentrations of 0.02 or 2 U/mL, 
mimicking the in vivo physiological conditions. The biomarker inputs were added 
systematically in four different combinations: 0,0, 0,1, 1,0 and 1,1 (for ALT,AST, 
respectively) where 0,0 and 1,1 combinations corresponded to the normal physiological 
and pathophysiological conditions of liver injury, respectively, while combinations 0,1 
and 1,0 were not definitive, since they might result from other than liver injury biological 
dysfunctions. Two reactions biocatalyzed by ALT and AST were coupled in the 
biocatalytic cascade through -ketoglutarate, Scheme 1. Even though logic 0 inputs were 
not the physical zero concentrations of the enzymes, and thus the biocatalytic cascade 
was active for all four combinations of the input signals, only 1,1 combination of the 
inputs resulted in higher rates of both biocatalytic reactions, yielding higher concentration 
of oxaloacetate.  
 
Oxaloacetate generated by the joint activity of the two input enzymes was converted 
to citrate with the help of the third enzyme, citrate synthase. This reaction fostered 
generation of the species capable of dissolving the alginate microspheres and releasing a 
drug-mimicking dye. It is worth mentioning that the byproduct of the third biocatalytic 
reaction, CoASH, was analyzed through its reaction with DTNB, Scheme 1. Since 
CoASH was produced in the 1:1 stoichiometry to citrate, the concentration of citrate was 
determined on the basis of production of CoASH in the presence of different 
combinations of the enzyme-input signals, Scheme 1, inset. Application of the 1,1 input 
combination corresponding to the liver injury resulted in 1 mM citrate after 60 min 
reaction, while the highest citrate concentration corresponding to the conditions different 
from liver injury was ca. 3-fold lower (0.34 mM) and it was achieved at the 1,0 input 
combination. After 1 h the activity of enzymes comes to saturation, so after that time 
increase in citrate concentration was not observed. Aiming at the drug-mimicking release 
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triggered specifically by the 1,1 input combination corresponding to the liver injury, the 
kinetics of dissolution of the alginate microspheres should be significantly different in the 
presence of 0.34 mM and 1 mM citrate, as demonstrated in the following sections of this 
paper. 
 
Recently, we reported an electrochemical fabrication of alginate thin-films cross-
linked with Fe3+ cations.89 In the present study we use the ability of the Fe3+ cations to 
form a complex with citrate: binding constant K1 (logK1 = 11.85).90 Thus, a ligand 
exchange reaction between citrate and alginate in the Fe3+-alginate complex initiates the 
alginate hydrogel dissolution. Note that the Ca2+ cations frequently used for the alginate 
cross-linking have a much weaker complex formation with citrate (logK1 = 3.5).90 
Therefore, citrate is not able to dissolve alginate hydrogels if they are cross-linked with 
Ca2+ cations. It should be noted that the present study aims at selective dissolution of the 
alginate microspheres at the citrate concentration of 1 mM achieved in the presence of 
1,1 combination of ALT/AST biomarkers, while the lower concentrations of citrate (up to 
0.34 mM at 1,0 input combination) should not result in the microsphere dissolution. 
Thus, the microspheres should be capped with protecting layers discriminating the effects 
of citrate at 0.34 and 1 mM concentrations. This was achieved by LbL deposition of poly-
L-lysine and alginate resulting in the alginate/poly-L-lysine/alginate (APA) 
microspheres, Scheme 2. The APA microspheres were visualized with the confocal 
microscope, Figure 1 (all the Figures are located at the end of this preprint, starting on 
page 27). While using FITC-labeled poly-L-lysine, the thickness of the inner poly-L-
lysine layer was estimated as ca. 18 μm and the size of Fe3+-cross-linked alginate core 
loaded with the rhodamine 6G dye was ca. 500 μm.  
 
The APA microspheres have demonstrated significant difference in their dissolution 
when they were reacted with 0.34 and 1 mM citrate solutions. Figure 2 depicts selected 
images of a single APA microsphere dissolution, obtained with the confocal microscope. 
Figure 3 shows the dynamics of the dissolution derived from the images obtained with 
the confocal microscopy. The APA microsphere was rapidly dissolved after the lag-
period of ca. 7 minutes when it was reacted with 1 mM citrate solution. On the other 
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hand, the APA microsphere was reacting very slowly with 0.34 mM citrate over the 
period of time longer than 60 min. (Movies showing time-dependent dissolution of the 
APA microspheres in the presence of 0.34 and 1 mM citrate are available in the 
Electronic Supplementary Information, which is available at the journal web site). In a 
control experiment an APA microsphere was reacted with 1 mM ascorbic acid which is 
known to react with Fe3+-cross-linked alginate hydrogel, reducing the Fe3+ cations and 
thus dissolving the hydrogel. Importantly, the protecting layers in the APA structure also 
slow down the microsphere dissolution in the presence of ascorbic acid preventing its 
penetration into the Fe3+-cross-linked alginate core. This result is particularly important 
for potential future applications of the APA microspheres in vivo where ascorbic acid that 
is present in blood (ca. 1 mM) and might be one of the main interferants. We note that 
citrate is also present in blood,91 but at concentrations (0.12 mM) which are too low to 
initiate the dissolution of the alginate microspheres. 
 
After studying the dissolution of a single APA microsphere, we investigated the 
process of the release of the drug-mimicking dye into the solution. In the first set of 
experiments the release was performed under mixing of the solution, thus enhancing the 
mass-transport of the dye after the dissolution of the APA microsphere induced by 
different combinations of the ALT/AST input signals. Figure 4 shows the kinetics of the 
fluorescence increase obtained from a single APA microsphere when introduced into a 
solution containing 0,0, 0,1, 1,0 or 1,1 combinations of the input signals. Notably the 
input combinations 0,0, 0,1 and 1,0 result in a very slow and small increase of the 
fluorescence, thus proving that the protecting two-layer shell on the APA microsphere 
keeps the dye-loaded core intact. On the other hand, the input combination 1,1 results in a 
fast significant increase of the fluorescence after the lag-period of ca. 40 min. In the 
control experiment performed in the presence of all components of the biocatalytic 
cascade except citrate synthase, thus prohibiting citrate formation, the dissolution of the 
microspheres was not observed within the studied time scale.     
 
Additional information on the properties of the APA microspheres, specifically, the 
process of release of the dye from the microspheres, can be obtained in experiments 
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whereby the dye diffuses without any initial mixing, upwards along the cuvette from its 
bottom where a single microsphere is located. Figure 5 shows the data sets taken for 
various concentrations of citrate. A standard diffusion theory was used for the time-
dependence of the cross-section-averaged concentration at height, x, upwards along the 
cuvette, similarly to the method used in the previous work.92 The concentration, c(x,t), 
averaged over the cuvette cross-section, was measured by fluorescent spectroscopy at x = 
6 mm, as described in the experimental section. The diffusion equation assuming that the 
microsphere size is small as compared to other dimensions, was taken as 
  
డ௖
డ௧ ൌ ܦ
డమ௖
డ௫మ ൅ ܵሺݐሻߜሺݔሻ, (1) 
 
for 0 ൑ ݔ ൏ ∞, with the reflecting boundary condition at x = 0, and with the source term, 
ܵሺݐሻߜሺݔሻ,  determined by the dye release. Here ߜሺݔሻ is the Dirac delta-function 
representing a point source, whereas the expression for ܵሺݐሻ	 is given in the next 
paragraph. The diffusion constant of the dye molecules, ܦ ൌ 2.8 ൈ 10ିଵ଴	m2sec–1 , is 
known.93 
 
We assume that the time scale of dissolution of the shell is t0, after which the core of 
radius R0 remains, containing N molecules of dye. As this core is decomposed, or the dye 
is leached out from it, the radius of the remaining dye-containing spherical volume, R(t), 
will decrease to zero. This process involves another time scale, tc. The quality of the 
available data only allows extraction of information on these two parameters, and 
therefore a relatively simple model of the dye etching should be used. For the present 
system, the concentration of the dye in the solution is too low, and its transport away 
from the dissolving core too fast to affect the rate of dye release. Basically, this 
corresponds to the assumption that in the Noyes–Whitney law,94 the concentration 
gradient in the near-surface diffusion-controlled layer is not significantly time- or core-
size dependent, and that the external (to that layer) concentration is small as compared to 
the internal one (at the dissolving core surface). Then the dye is released at a constant rate 
per unit area of the core of radius R(t), and therefore the volume, ܸ ൌ 4ߨܴଷ/3, of the 
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dye-containing core shrinks according to డ௏డ௧ ∝ 4ߨܴଶ. One can then easily show that this 
approach leads to a linear decrease ܴሺݐሻ ൌ ܴ଴ ቀ1 െ ௧ି௧బ௧೎ ቁ. Thus, the core radius decreases 
from R0 at t0 to zero at time t0 + tc. The amount of dye released can then be calculated, 
and the source term in the diffusion equation turns out to be given by ܵሺݐሻ ൌ ଷே஺ோబమ௧೎ ܴ
ଶሺݐሻ 
for times t0 < t < t0 + tc, and S(t) = 0 otherwise, where A is the cross-section area of the 
cuvette. 
 
The diffusion equation can now be solved analytically for 0 ൑ ݔ ൏ ∞ , where no 
upper limit is assumed because it can be estimated that the height of the column of 
solution in the cuvette, 12 mm, will affect the concentration only after times of 
approximately 700 min, safely outside our measurement range (we also tested the latter 
assumption by numerical solutions with the reflecting boundary condition at the top of 
the liquid column). For t0 ≤ t ≤ t0 + tc, we get  
 
ܿሺݔ, ݐሻ ൌ ׬ ݀߬௧௧బ
ଷே
஺௧೎ ቀ1 െ
ఛି௧బ
௧೎ ቁ
ଶ ଵ
ඥగ஽ሺ௧ିఛሻ ݁
ି ೣమరವሺ೟షഓሻ, (2) 
 
with the upper limit of integration replaced by t0 + tc for t > t0 + tc, and obviously c(x,t) = 
0 for t < t0. Least-squares data-fitting results, using the standard approaches (including 
error estimates),95 are presented in Table 1 (see page 24). The sums of the times, t0 + tc, 
are generally consistent with the earlier estimates for the overall time of the dye 
concentration buildup measured by the microsphere dissolution in the system with 
mixing. 
 
The diffusion-theory study clearly confirms that two separate time scales are 
involved in the process. This is illustrated in Figure 6, in which we used experimental 
parameters for all the quantities but the time scales. We note that the time scale t0 simply 
represents the offset in the concentration buildup to positive times, due to the need to first 
dissolve the shell. A single additional time scale for the dye-containing core 
decomposition, here illustrated by varying tc values, cannot modify this offset. Rather, 
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increasing it leads to slower concentration buildup at the distance x from the cuvette 
bottom. Note that for larger times than those of our experiment, the concentration at x 
will actually decrease, to zero if there is no reflecting liquid-column top — as assumed 
for Equation (2). Our time-dependence form for the remaining dye-containing core radius 
is sketched in the inset in Figure 6. In reality, the effective radius Reff defined, for 
instance, via Reff(t)/R0 = (n(t)/N)3, were n(t) is the remaining undissolved dye at time t, 
with n(0) = N, is likely a smooth function of time, but requiring two time scales for 
describing its time dependence: one for the shall and the other for the dye-containing 
core. 
 
 
4. CONCLUSIONS 
 
The present study has demonstrated that the drug-mimicking release process can be 
triggered by at least two biomarker-signals logically processed by a biocatalytic cascade 
featuring binary AND logic operation. Simultaneous appearance of two biomarkers at 
pathophysiological elevated concentrations (the 1,1 input combination) resulted in the 
alginate microsphere dissolution and release of the loaded dye that mimics a drug. 
Importantly, normal physiological concentrations of the biomarkers (the 0,0 input 
combination) or even a single-biomarker elevated concentration (the 0,1 and 1,0 input 
combinations) do not result in the “drug” release at least on the studied time-scale. The 
effective discrimination between the 1,1 inputs indicative of the liver injury conditions 
and all the other input combinations, corresponding to the normal physiology (0,0) or to 
another pathophysiology different from the liver injury (0,1 and 1,0), was achieved by 
protecting the dye-loaded alginate core with the two-layer polymer shell. Theoretical 
model of the dye release and transport has allowed evaluation of the time scales of the 
microsphere dissolution process, and discrimination between the initial shell 
decomposition and later release of the dye from the alginate core. Once the kinetics of the 
dye release from a microsphere is known based on studies in simple diffusion situations, 
such as reported here, the obtained information can be used as input for evaluation of dye 
transport in more complicated situations, involving convective diffusion and complicated 
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flow patterns, for instance, in blood vessels, by using standard computational fluid-
dynamics techniques. 
 
Despite the fact that the studied system aims only at the demonstration of the concept, 
practical applications are feasible. However, after the successful implementation of the 
AND logic operation to the drug-mimicking release process still there are unsolved 
problems which require additional work. The present study was performed using 
solutions artificially spiked with the biomarker-inputs mimicking normal physiological 
and pathophysiological conditions (defined as logic 0 and 1 inputs, respectively). In the 
continued study the inputs should be natural biologically produced materials obtained 
from animal or human biomedical samples, similarly to our recent study where porcine 
samples were applied for the logic analysis of liver injury biomarkers.99 It has been 
already shown that similar binary logic systems processing injury biomarkers can operate 
in human serum solutions.80,96 Preliminary experiments also demonstrated that Fe3+-
crosslinked alginate can be stable in human serum and its dissolution can be triggered by 
chemical signals. Still additional work will be required to optimize the structure and 
composition of the drug releasing microcapsules for their robust operation in human 
serum solutions or other physiological liquids. The issue of the potential toxicity of Fe2+ 
ions97 released upon dissolution of the Fe3+-crosslinked alginate microspheres should be 
addressed. The concomitant release of Fe2+ ions upon complete decomposition of a single 
microsphere results in dissolution of ca. 10 μg iron ions. This amount should be 
compared with iron content (10-18 mg daily) in food supplements according to the 
Recommended Dietary Allowance (RDA) of nutritional elements.98 One can conclude 
that the iron release from the microsphere is much below the recommended iron 
consumption, thus there is no any toxicity issue associated with the Fe2+ ions. The last but 
not the least, the present study utilized a drug-mimicking material, thus limiting the 
practical applicability of the developed system. It should be noted that another study 
performed in our lab has demonstrated that the Fe3+-crosslinked alginate thin-films can be 
applied for encapsulation and triggered release of lysozyme, which is a real antimicrobial 
drug.100 In the next step of the project, which is underway, real drug compensating liver 
injury problems will be used instead of a drug-mimicking dye. This approach will also be 
– 16 – 
	
extended to other biomarkers signaling different kinds of pathophysiological problems, 
and the alginate microspheres will be loaded with the corresponding drugs. 
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Table 1: Results of fitting the time-dependent data presented in Figure 5 
according to Equation (2). Note that all the parameters but the fitted values of 
t0 and tc are known independently. 
 
Input combinations t0 / min tF /min 
1,1 8.2 ± 0.6 49.6 ± 2.5 
1,0 64.8 ± 3.1 116.4 ± 3.8 
0,1 78.3 ± 3.5 123.4 ± 4.2 
  
– 25 – 
	
 
 
 
 
 
 
 
 
Scheme 1. The biocatalytic cascade mimicking the AND logic gate activated by two 
input signals, ALT and AST, which are biomarkers of liver injury. The production of 
citrate, which is the final product of the biocatalytic cascade, is indirectly analyzed by 
measuring CoASH byproduct using DTNB-assay for thiol groups. Citrate induces 
dissolution of the alginate microspheres shown in the micrograph. 
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Scheme 2. The cartoon shows the APA microsphere composition which includes a 
central core of Fe3+-cross-linked alginate gel loaded with rhodamine 6G dye and a two-
layer shell consisting of a poly-L-lysine inner layer and sodium alginate outer layer. 
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Figure 1. Images taken using a confocal optical microscope, where (A) is optical 
visualization of the microspheres (without fluorescence), (B) is a fluorescent image of the 
rhodamine-loaded core, and (C) shows a fluorescent image of the FITC-labeled poly-L-
lysine outer layer in the shell (note that rhodamine was not included in the core). 
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Figure 2. Fluorescence images of the dissolving microspheres upon reacting with 
the different citrate concentration and obtained with a confocal microscope after different 
reaction time: (A) 1 mM, 3 min, (B) 0.34 mM, 3 min, (C) 1 mM, 20 min, (D) 0.34 mM, 
20 min. The progress in the microsphere dissolution can be observed when comparing 
images A and C, B and D. The images represent selected frames from movies which are 
available in the Electronic Supplementary Information. 
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Figure 3. The kinetics of the microsphere dissolution upon reacting with: a) 1 mM 
citrate, b) 0.34 mM citrate, c) 1 mM ascorbic acid—a major possible interferant in blood. 
The kinetic was derived from the fluorescence images similar to those shown in Figure 2 
and it was measured as the pixel brightness in a square marked in image (C) and in other 
similar images, Figure 2. The same image area was analyzed for brightness in all images 
recorded over the reaction time. 
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Figure 4. The kinetics of the rhodamine 6G release from a single APA microsphere 
in the presence of the biocatalytic cascade shown in Scheme 1, activated with different 
combinations of the ALT/AST input signals: 0,0, 1,0, 0,1 and 1,1. The release was 
performed under mixing conditions. The experiments were performed in PBS buffer. The 
rhodamine 6G concentration was calculated from the fluorescence measurements using a 
calibration plot. 
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Figure 5. Data sets for concentration measurements at height x = 6 mm upwards 
along the cuvette, for various input combination a) 1,1, b) 1,0, c) 0,1, hence different 
concentrations of citrate. The experiments were performed in PBS buffer. The model 
fitting curves are based on the diffusion theory and assumptions of the dye release 
kinetics as described in the text. 
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Figure 6: Time dependence, Equation (2), at fixed x, for illustrative values t0 = 10 
min, and, in decreasing curve heights order, tc = 50, 75, 100, 125, 150 min. Note that for 
larger times these curves are not monotonically increasing (see text). The inset 
schematically shows the assumed time dependence of the dye-containing core radius 
(solid line) and the actual effective radius (dotted line). 
